Covid-19 vaccines approval spikes Sensex to new high
Mumbai/UNI: The benchmark Sensex rallied 307.82 points on Monday and closed at an all time high 48,176.80 as the investors' sentiments were lifted over emergency approval of two Covid-19 vaccines in India.
The Sensex registered 0.6 per cent increase, while Nifty jumped by 0.82 pc to close at record 14,132.90.
ONGC was the top gainer, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T.
On the other hand, Kotak Bank, Bajaj Finance, Asian Paints, Titan and PowerGrid were among the laggards.
India, which has the second-highest Covid-19 infections in the world, on Sunday approved for emergency use two coronavirus vaccines – one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
The country is expected to start a massive immunisation program shortly. Serum Institute of India, the local maker of the AstraZeneca/Oxford vaccine.
In global markets, stock exchanges in Europe as well as in Shanghai, Seoul and Hong Kong ended on a positive note.